$CWBR
CohBar Inc Stock $cwbr

$cwbr Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000121390022070161 Filed on November 08, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.717M	$390.1K	$1.777M
YoY Change	-13.41%	-78.05%	29.71%
% of Gross Profit
Research & Development	$2.205M	$1.037M	$1.634M
YoY Change	176.17%	-36.53%	30.72%
% of Gross Profit
Depreciation & Amortization	$12.49K	$21.72K	$34.88K
YoY Change	-62.35%	-37.73%	-12.8%
% of Gross Profit
Operating Expenses	$3.923M	$2.471M	$3.411M
YoY Change	41.02%	-27.56%	30.19%
Operating Profit		-$2.471M	-$3.411M
YoY Change		-27.56%
Interest Expense	$126.0K	$78.90K	-$10.69K
YoY Change	-1276.66%	-838.07%	-91.78%
% of Operating Profit
Other Income/Expense, Net		$78.90K	-$10.70K
YoY Change		-837.75%
Pretax Income	-$3.797M	-$2.392M	-$3.422M
YoY Change	35.96%	-30.1%	5.61%
Income Tax
% Of Pretax Income
Net Earnings	-$3.797M	-$2.392M	-$3.422M
YoY Change	35.96%	-30.1%	5.61%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.82	-$1.61
Diluted Earnings Per Share	-$1.30	-$0.82	-$53.56K
COMMON SHARES
Basic Shares Outstanding	2.907M shares	87.15M shares	2.130M shares
Diluted Shares Outstanding		2.903M shares	2.130M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$15.74M	$18.34M	$15.02M
YoY Change	-40.04%	22.14%	-35.72%
Cash & Equivalents	$5.931M	$4.211M	$9.180M
Short-Term Investments	$9.807M	$14.13M	$5.835M
Other Short-Term Assets	$453.7K	$683.4K	$810.3K
YoY Change	-13.97%	-15.67%	30.7%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$16.22M	$19.02M	$15.83M
YoY Change	-39.81%	20.2%	-34.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$65.51K	$174.8K	$293.5K
YoY Change	-74.86%	-40.45%	-31.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$63.57K	$76.60K	$69.62K
YoY Change	-8.69%	10.02%	-0.54%
Total Long-Term Assets	$147.2K	$269.8K	$382.7K
YoY Change	-57.9%	-29.52%	-26.4%
TOTAL ASSETS
Total Short-Term Assets	$16.22M	$19.02M	$15.83M
Total Long-Term Assets	$147.2K	$269.8K	$382.7K
Total Assets	$16.37M	$19.29M	$16.21M
YoY Change	-40.04%	19.03%	-33.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$180.1K	$257.3K	$1.307M
YoY Change	-51.58%	-80.31%	178.07%
Accrued Expenses	$327.9K	$92.49K	$668.6K
YoY Change	67.26%	-86.17%	-51.9%
Deferred Revenue
YoY Change
Short-Term Debt			$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$361.9K
YoY Change	-100.0%	-100.0%	-23.0%
Total Short-Term Liabilities	$1.034M	$546.5K	$2.337M
YoY Change	-38.79%	-76.62%	-0.11%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.034M	$546.5K	$2.337M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$1.034M	$546.5K	$2.337M
YoY Change	-38.79%	-76.62%	-57.19%
SHAREHOLDERS EQUITY
Retained Earnings	-$96.91M	-$93.11M
YoY Change	14.37%
Common Stock	$2.907K	$2.907K
YoY Change	-96.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$15.33M	$18.75M	$13.87M
YoY Change
Total Liabilities & Shareholders Equity	$16.37M	$19.29M	$16.21M
YoY Change	-40.04%	19.03%	-33.84%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$3.797M	-$2.392M	-$3.422M
YoY Change	35.96%	-30.1%	5.61%
Depreciation, Depletion And Amortization	$12.49K	$21.72K	$34.88K
YoY Change	-62.35%	-37.73%	-12.8%
Cash From Operating Activities	-$2.727M	-$1.789M	-$3.266M
YoY Change	0.49%	-45.24%	23.73%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$0.00
YoY Change			-100.0%
Acquisitions
YoY Change
Other Investing Activities	$4.447M	$3.087M	$6.385M
YoY Change	-128.84%	-51.65%	-174.07%
Cash From Investing Activities	$4.447M	$3.087M	$6.385M
YoY Change	-128.84%	-51.65%	-173.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	34.88K	4.459M
YoY Change	-100.0%	-99.22%	-67.4%
NET CHANGE
Cash From Operating Activities	-2.727M	-1.789M	-3.266M
Cash From Investing Activities	4.447M	3.087M	6.385M
Cash From Financing Activities	0.000	34.88K	4.459M
Net Change In Cash	1.719M	1.333M	7.577M
YoY Change	-141.05%	-82.4%	215.72%
FREE CASH FLOW
Cash From Operating Activities	-$2.727M	-$1.789M	-$3.266M
Capital Expenditures	$0.00	$0.00	$0.00
Free Cash Flow	-$2.727M	-$1.789M	-$3.266M
YoY Change	0.49%	-45.24%	24.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Short Term Borrowings ShortTermBorrowings		usd
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4992145	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q3	us-gaap	Short Term Investments ShortTermInvestments	14128120	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	21253866	usd
CY2021Q4	cwbr	Vendor Receivable VendorReceivable	173499	usd
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2906926	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4211379	usd
	dei	Entity File Number EntityFileNumber	001-38326
	dei	Entity Registrant Name EntityRegistrantName	COHBAR, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1299952
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1455 Adams Drive
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 2050
	dei	Entity Address City Or Town EntityAddressCityOrTown	Menlo Park
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94025
	dei	City Area Code CityAreaCode	(650)
	dei	Local Phone Number LocalPhoneNumber	446-7888
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	CWBR
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	683359	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	527380	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	19022858	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	26946890	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	174773	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	260612	usd
CY2022Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	18389	usd
CY2021Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	19309	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	76596	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	69620	usd
CY2022Q3	us-gaap	Assets Assets	19292616	usd
CY2021Q4	us-gaap	Assets Assets	27296431	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	257317	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	371993	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	92487	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	196020	usd
CY2022Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	196695	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	754314	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	0	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	8723	usd
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	366277	usd
CY2022Q3	us-gaap	Liabilities Liabilities	546499	usd
CY2021Q4	us-gaap	Liabilities Liabilities	1688604	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	12000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	12000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2906926	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2906926	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2877985	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2877985	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	2907	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	2878	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	111855921	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	110339011	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-93112711	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-84734062	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	18746117	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25607827	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19292616	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27296431	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1037111	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1634063	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3730319	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6906510	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1433699	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1777000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4735402	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5720043	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	2470810	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	3411063	usd
	us-gaap	Operating Expenses OperatingExpenses	8465721	usd
	us-gaap	Operating Expenses OperatingExpenses	12626553	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2470810	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3411063	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8465721	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12626553	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	78902	usd
CY2021Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1226	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	97274	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	4366	usd
CY2021Q3	us-gaap	Interest Expense Other InterestExpenseOther	7562	usd
	us-gaap	Interest Expense Other InterestExpenseOther	1479	usd
	us-gaap	Interest Expense Other InterestExpenseOther	32547	usd
CY2021Q3	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	-4359	usd
	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	-8723	usd
	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	-28733	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	78902	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10695	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	87072	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-56914	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2391908	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3421758	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	20713089	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	390062	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	25025	usd
CY2022Q3	cwbr	Sale Of Common Stock In Atm Net SaleOfCommonStockInATMNet	9917	usd
CY2022Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1:30
CY2022Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-68	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2391908	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1281441	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	18746117	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	18487155	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	320444	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1959837	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8378649	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12683467	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.82
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.61
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.9
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.09
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2903403	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2129686	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2890723	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2081318	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	25607827	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	456423	usd
CY2022Q1	cwbr	Sale Of Common Stock In Atm Net SaleOfCommonStockInATMNet	200624	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3261773	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	23003101	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	434956	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2724968	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	958847	usd
CY2021Q1	cwbr	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	67536	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-4038344	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	15795638	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	957558	usd
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	621822	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-5223365	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	12151653	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	681835	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	16814	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	157300	usd
CY2021Q3	cwbr	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	2021940	usd
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2262964	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3421758	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	13870748	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8378649	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12683467	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	86759	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	22345994	usd
	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	53895000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	107735	usd
	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	34634000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	7078024	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	8350	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	27513	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	373	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1220	usd
	cwbr	Discount On Investments DiscountOnInvestments	40746	usd
	cwbr	Discount On Investments DiscountOnInvestments	-2501	usd
	cwbr	Vendor Receviables VendorReceviables	-173499	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	155979	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	396615	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-114676	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	579329	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-103533	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-986129	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-557619	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-340345	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7719288	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11733423	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6398	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2359	usd
	cwbr	Payment For Security Deposit PaymentForSecurityDeposit	6976	usd
	cwbr	Payment For Security Deposit PaymentForSecurityDeposit	2217	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	46810000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	12277032	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	25025	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	16814	usd
	cwbr	Proceeds From The Atthe Market Offering Net ProceedsFromTheAttheMarketOfferingNet	210541	usd
	cwbr	Proceeds From The Atthe Market Offering Net ProceedsFromTheAttheMarketOfferingNet	2884786	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2089476	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-375000	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-365000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1116147	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	-68	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-139502	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5742223	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-780766	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	6285832	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4992145	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2894575	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4211379	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9180407	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1332	usd
	us-gaap	Interest Paid Net InterestPaidNet	114411	usd
	us-gaap	Interest Paid Net InterestPaidNet	89908	usd
CY2022Q3	cwbr	Working Capital WorkingCapital	18500000	usd
	us-gaap	Stockholders Equity Other StockholdersEquityOther	18700000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	8400000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	7700000	usd
CY2022Q3	us-gaap	Investments And Cash InvestmentsAndCash	18300000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.35in"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at dates of the financial statements and the reported amounts of revenue and expenses during the periods. Actual results could differ from these estimates. The Company’s significant estimates and assumptions include the fair value of financial instruments, stock-based compensation and the valuation allowance relating to the Company’s deferred tax assets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps"><b> </b></span></p>
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Grant In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantInPeriodWeightedAverageGrantDateFairValue	4.53
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0in 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps"><b><i>Concentrations of Credit Risk</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">The Company maintains deposits in a financial institution which is insured by the Federal Deposit Insurance Corporation (“FDIC”). At various times, the Company has deposits in this financial institution in excess of the amount insured by the FDIC. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></p>
CY2022Q3	us-gaap	Us Government Securities At Carrying Value USGovernmentSecuritiesAtCarryingValue	14100000	usd
CY2021Q4	us-gaap	Us Government Securities At Carrying Value USGovernmentSecuritiesAtCarryingValue	21300000	usd
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	4600000	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P4Y
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1510720	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	865512	shares
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Contractual Life Years ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsContractualLifeYears	P6Y3M7D
CY2022Q3	us-gaap	Payments For Rent PaymentsForRent	100000	usd
CY2021Q3	us-gaap	Payments For Rent PaymentsForRent	100000	usd
	us-gaap	Payments For Rent PaymentsForRent	300000	usd
	us-gaap	Payments For Rent PaymentsForRent	300000	usd
	cwbr	Issuance And Sale Of Stock IssuanceAndSaleOfStock	17000000	shares
CY2022Q3	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	12000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
	cwbr	Stock Options Term StockOptionsTerm	P10Y
	cwbr	Awardee Over A Period AwardeeOverAPeriod	P4Y
	cwbr	Options To Purchase Common Stock OptionsToPurchaseCommonStock	53200	shares
	cwbr	Weighted Average Exercise Price Expired WeightedAverageExercisePriceExpired	56.39	usd
CY2022Q3	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	17639	usd
CY2021Q3	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	23362	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	64048	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	200092	usd
CY2022Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	372423	usd
CY2021Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	658473	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1217393	usd
	cwbr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 One SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2One	P6Y3M7D
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1759745	usd
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Option Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantsInPeriodGross	19367	usd
	cwbr	Share Based Compensations Arrangement By Shares Based Payment Award Options Exercisable Granted. ShareBasedCompensationsArrangementBySharesBasedPaymentAwardOptionsExercisableGranted.	278	usd
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.42
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceGranted	10.42
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	390062	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	681835	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1281441	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1959837	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	366411	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	204230	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	51.3
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	47.4
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	47.4
	cwbr	Stock Options Outstan Share Based Compensation Arrangement By Share Based Payment Award Option Forfeitures And Expirations In Periodding Cancelledin Share StockOptionsOutstanShareBasedCompensationArrangementByShareBasedPaymentAwardOptionForfeituresAndExpirationsInPerioddingCancelledinShare	53227	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	332551	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	197585	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	49.08
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	43.12
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	43.12
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y3M7D
CY2022Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	332551	shares
CY2022Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	197585	shares
CY2022Q3	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Prices ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrices	17.83
	cwbr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P3Y7M28D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1187803	shares
CY2021Q4	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Option Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisableNumber	1187664	shares
CY2021Q4	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice	31.35
CY2021Q4	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Weighted Average Exercise Price Exercisable Balance ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePriceExercisableBalance	31.35
CY2021Q4	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Prices ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrices	15.9
	cwbr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term One SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermOne	P4Y4M17D
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Option Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionForfeituresAndExpirationsInPeriod	-9634	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1178169	shares
CY2022Q3	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Option Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisableNumber	1178169	shares
CY2022Q3	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePrice	30.67
CY2022Q3	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Weighted Average Exercise Price Exercisable Balance ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageExercisePriceExercisableBalance	30.67
	cwbr	Market Price Percentage MarketPricePercentage	0.85	pure
	us-gaap	Stock Issued During Period Shares Employee Stock Ownership Plan StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan	5600	shares
CY2022Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	25000	usd
CY2022Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	10500	shares
CY2022Q3	cwbr	Net Proceeds NetProceeds	200000	usd
	cwbr	Balance Amount BalanceAmount	5000000	usd
CY2022Q3	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	390062	usd
CY2021Q3	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	681835	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1281441	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1959837	usd
CY2022Q3	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	21716	usd
CY2021Q3	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	34594	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	86759	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	107735	usd
CY2022Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	411778	usd
CY2021Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	716429	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1368200	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	2067572	usd
CY2021Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	4174	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	8350	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	27512	usd
CY2021Q3	us-gaap	Other Expenses OtherExpenses	4174	usd
	us-gaap	Other Expenses OtherExpenses	8350	usd
	us-gaap	Other Expenses OtherExpenses	27512	usd
CY2022Q3	cwbr	Total Noncash Expenses TotalNoncashExpenses	411778	usd
CY2021Q3	cwbr	Total Noncash Expenses TotalNoncashExpenses	720603	usd
	cwbr	Total Noncash Expenses TotalNoncashExpenses	1376550	usd
	cwbr	Total Noncash Expenses TotalNoncashExpenses	2095084	usd
	cwbr	Totaling In Principal And Interest TotalingInPrincipalAndInterest	500000	usd
	cwbr	Totaling In Principal And Interest TotalingInPrincipalAndInterest	100000	usd
	cwbr	Net Proceeds From Sale Of Unused Equipment NetProceedsFromSaleOfUnusedEquipment	100000	usd
CY2022Q3	cwbr	Vendor Receivable VendorReceivable		usd
	us-gaap	Revenues Revenues		usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2081318	shares
	cwbr	Vendor Receviables VendorReceviables		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercised		shares
	cwbr	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercised ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercised
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Exercise ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceExercise
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Exercised Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisedDateFairValue
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Contractual Life Years ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedContractualLifeYears
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedIntrinsicValue		usd
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Cancelled ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableCancelled		shares
	cwbr	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Cancelled ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageCancelled
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Cancelled ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceCancelled
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Cancelled Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageCancelledDateFairValue
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Cancelledd Contractual Life Years ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelleddContractualLifeYears
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledIntrinsicValue		usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2021Q4	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value One ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueOne		usd
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Grant In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantInPeriodGross		shares
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableGranted		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	cwbr	Share Based Payment Arrangement Weighted Average Exercise Price Exercisable Granted ShareBasedPaymentArrangementWeightedAverageExercisePriceExercisableGranted		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisables Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisablesExercised		shares
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue		usd
	cwbr	Stock Issued During Period Shares Warrants Exercised StockIssuedDuringPeriodSharesWarrantsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercised Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisedFairValue
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedIntrinsicValue		usd
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Cancelled ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableCancelled		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Cancelled Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageCancelledFairValue
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Cancelled Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageCancelledFairValue
CY2022Q3	cwbr	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value One ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValueOne		usd
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts		usd
CY2022Q3	us-gaap	Other Expenses OtherExpenses		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001522602

Files In Submission

Name	View Source	Status
cwbr-20220930_pre.xml	Edgar Link	unprocessable
cwbr-20220930_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cwbr-20220930_lab.xml	Edgar Link	unprocessable
0001213900-22-070161-index-headers.html	Edgar Link	pending
0001213900-22-070161-index.html	Edgar Link	pending
0001213900-22-070161.txt	Edgar Link	pending
0001213900-22-070161-xbrl.zip	Edgar Link	pending
cwbr-20220930.xsd	Edgar Link	pending
cwbr-20220930_cal.xml	Edgar Link	unprocessable
f10q0922ex31-1_cohbarinc.htm	Edgar Link	pending
f10q0922ex31-2_cohbarinc.htm	Edgar Link	pending
f10q0922ex32-1_cohbarinc.htm	Edgar Link	pending
f10q0922_cohbarinc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
f10q0922_cohbarinc_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CWBR
CohBar Inc Stock $cwbr

2022 Q4 Form 10-Q Financial Statement

#000121390022070161 Filed on November 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWBR CohBar Inc Stock $cwbr

2022 Q4 Form 10-Q Financial Statement

#000121390022070161 Filed on November 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWBR
CohBar Inc Stock $cwbr